Expression of concern

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Expression of concern Details

Retraction Reason:

Concerns/Issues About Data

Nature of Retraction:

Expression of concern

Citations (163)

163
Total Citations
105
Post-Retraction
(64.4%)
58
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
8 Within 30 days
73 Within 1 year
9 After 2+ years
1232 Days since retraction (latest)
Production, Regulation, and Distribution of COVID-19 Treatments and Vaccines
Belinda Bennett, Ian Freckelton, Gabrielle Wolf
Oxford University Press eBooks
Published: Jan 2023
346 days after retraction
Litigation and Legal Challenges to Emergency Orders
Belinda Bennett, Ian Freckelton, Gabrielle Wolf
Oxford University Press eBooks
Published: Jan 2023
346 days after retraction
Criminal Justice Issues and the COVID-19 Pandemic
Belinda Bennett, Ian Freckelton, Gabrielle Wolf
Oxford University Press eBooks
Published: Jan 2023
346 days after retraction
COVID-19, Law & Regulation
Belinda Bennett, Ian Freckelton AO KC, Gabrielle Wolf
Oxford University Press eBooks
Published: Jan 2023
6 citations
346 days after retraction
Restrictions on Movement
Belinda Bennett, Ian Freckelton, Gabrielle Wolf
Oxford University Press eBooks
Published: Jan 2023
3 citations
346 days after retraction
Use of Antiviral Agents and other Therapies for COVID-19
Mark A. T. Blaskovich, Anthony D. Verderosa
Seminars in Respiratory and Critical Care Medicine
Published: Jan 2023
7 citations
343 days after retraction
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Mohsen Nabi‐Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor et al. (9 authors)
Inflammopharmacology Open Access
Published: Jan 2023
15 citations
334 days after retraction
The Place of Ivermectin in the Management of Covid-19: State of the Evidence
Babalola O.E, Ajayi A.A
Medical Research Archives Open Access
Published: Jan 2023
328 days after retraction
Metabolites and metabolomics in COVID-19
Damodara Gowda, Adithi Kellarai, Pramukh Subrahmanya Hegde et al. (6 authors)
Elsevier eBooks
Published: Jan 2023
328 days after retraction
Appraising the decision-making process concerning COVID-19 policy in postsecondary education in Canada: A critical scoping review protocol
Claudia Chaufan, Laurie Manwell, Benjamin Gabbay et al. (5 authors)
AIMS Public Health Open Access
Published: Jan 2023
1 citation
328 days after retraction
COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function
James A. Thorp, Claire Rogers, Michael P. Deskevich et al. (7 authors)
Unknown Journal Open Access
Published: Dec 2022
9 citations
326 days after retraction
The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic
Andrew Hill, Manya Mirchandani
Journal of Antimicrobial Chemotherapy Open Access
Published: Dec 2022
4 citations
324 days after retraction
A Gadolinium-Based Magnetic Ionic Liquid for Dispersive Liquid–Liquid Microextraction of Ivermectin from Environmental Water
Mohamed A. Abdelaziz, A.M. Saleh, Fotouh R. Mansour et al. (4 authors)
Journal of Chromatographic Science
Published: Dec 2022
14 citations
315 days after retraction
Comparing the demographics and laboratory biomarkers of the COVID-19 Omicron wave and the Alpha wave in a predominantly Afro-Caribbean patient population in New York City
Hye Won Shin, Alecia James, Theresa Feng et al. (5 authors)
Pneumonia Open Access
Published: Nov 2022
1 citation
291 days after retraction
Information Technology and Management, Misinformation, and the Impact on Patient Safety and Outcomes
David J. Ranney, Amir Adolphe
Advances in healthcare information systems and administration book series
Published: Nov 2022
273 days after retraction
Effect of Ivermectin prophylaxis in prevention of COVID 19: Meta-analysis and systematic review
Manisha Kujur, Kumari Asha Kiran, Alka Rashmi Nag et al. (6 authors)
Journal of Family Medicine and Primary Care Open Access
Published: Nov 2022
267 days after retraction
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021
Martin Ho, Mina Tadrous, Anita Iacono et al. (5 authors)
Journal of Antimicrobial Chemotherapy Open Access
Published: Oct 2022
5 citations
260 days after retraction
The pharmaceutical industry is dangerous to health. Further proof with COVID-19
Fabien Deruelle
Surgical Neurology International Open Access
Published: Oct 2022
20 citations
256 days after retraction
Early Outpatient Treatment of COVID-19: A Retrospective Analysis of 392 Cases in Italy
Marco Cosentino, Veronica Vernocchi, Stefano De Martini et al. (11 authors)
Journal of Clinical Medicine Open Access
Published: Oct 2022
7 citations
253 days after retraction
Novel α-aminophosphonate derivates synthesis, theoretical calculation, Molecular docking, and in silico prediction of potential inhibition of SARS-CoV-2
Rachida Kerkour, Nadjib Chafai, Ouahiba Moumeni et al. (4 authors)
Journal of Molecular Structure Open Access
Published: Sep 2022
47 citations
234 days after retraction
COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function
James A. Thorp, Claire Rogers, Michael P. Deskevich et al. (7 authors)
Unknown Journal Open Access
Published: Sep 2022
4 citations
233 days after retraction
Comparing the demographics and laboratory biomarkers of the COVID-19 Omicron wave and the Alpha wave in a predominantly Afro-Caribbean patient population in New York City
Hye Won Shin, Alecia James, Theresa Feng et al. (5 authors)
Research Square (Research Square) Open Access
Published: Sep 2022
214 days after retraction
Ivermectin A Potential Treatment In Covid-19, Related to Critical Illness
Rashid Qadeer, Syed Muhmmad Kashif, Darshan Kumar et al. (6 authors)
Unknown Journal Open Access
Published: Aug 2022
1 citation
205 days after retraction
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
Jaqueline C. Stone, Pisirai Ndarukwa, David Scheim et al. (7 authors)
Biologics Open Access
Published: Aug 2022
11 citations
205 days after retraction
Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis
Stephanie Weibel, Maria Popp, Stefanie Reis et al. (6 authors)
Research Synthesis Methods Open Access
Published: Aug 2022
61 citations
203 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal Open Access
Published: Aug 2022
202 days after retraction
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Anan Manomaipiboon, Kittisak Pholtawornkulchai, Sujaree Poopipatpab et al. (8 authors)
Trials Open Access
Published: Aug 2022
11 citations
200 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal Open Access
Published: Aug 2022
192 days after retraction
Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data
Eleftherios Gkioulekas, Peter A. McCullough, Vladimir Zelenko
COVID Open Access
Published: Aug 2022
1 citation
192 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal Open Access
Published: Aug 2022
191 days after retraction
Ethical research in public policy
Paul Spicker
Policy Press eBooks Open Access
Published: Jul 2022
172 days after retraction
Ethical research in public policy
Paul Spicker
Policy Press eBooks Open Access
Published: Jul 2022
172 days after retraction
Effect of combined use of ivermectin and colchicine in COVID-19 patients
Rania Gamal El Sayed, Amr Fouad Hafez, Adham Magdy Ahmed Mohammed Haggag et al. (4 authors)
Egyptian Journal of Anaesthesia Open Access
Published: Jun 2022
3 citations
135 days after retraction
Ivermectin for preventing and treating COVID-19
Maria Popp, Stefanie Reis, Selina Schießer et al. (10 authors)
Cochrane library Open Access
Published: Jun 2022
158 citations
134 days after retraction
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
BMC Pharmacology and Toxicology Open Access
Published: Jun 2022
15 citations
131 days after retraction
Recent advances in avermectin chemistry
Leonid G. Menchikov, М. Х. Джафаров, И. В. Заварзин
Russian Chemical Reviews
Published: Jun 2022
5 citations
126 days after retraction
The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
Helen Onyeaka, Phemelo Tamasiga, Joy Onyinyechi Chionuma et al. (5 authors)
Clinical Epidemiology and Global Health Open Access
Published: Jun 2022
6 citations
121 days after retraction
Identifying and managing problematic trials: a Research Integrity Assessment (RIA) tool for randomized controlled trials in evidence synthesis
Stephanie Weibel, Maria Popp, Stefanie Reis et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Jun 2022
5 citations
118 days after retraction
A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren et al. (7 authors)
Journal of Genetic Engineering and Biotechnology Open Access
Published: May 2022
20 citations
106 days after retraction
Cardiac pathology in COVID-19 patients: state of the problem (literature review)
V. Shumakov, I. Malynovska, Н. Н. Терещенко et al. (4 authors)
Bukovinian Medical Herald Open Access
Published: May 2022
105 days after retraction
Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media
Manal Bin Qabbus, Katey S. Hunt, Joshua Dynka et al. (6 authors)
Toxicology and Applied Pharmacology
Published: May 2022
1 citation
102 days after retraction
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
H. Tanioka, Sayaka Tanioka, Kimitaka Kaga
Research Square (Research Square) Open Access
Published: May 2022
95 days after retraction
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic
Ajay Kumar Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology Open Access
Published: May 2022
5 citations
85 days after retraction
Nanovectorization of Ivermectin to avoid overdose of drugs
Éric Duverger, Guillaume Herlem, Fabien Picaud
Journal of Biomolecular Structure and Dynamics
Published: Apr 2022
78 days after retraction
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
Brit Long, Summer Chavez, Brandon M Carius et al. (7 authors)
The American Journal of Emergency Medicine Open Access
Published: Mar 2022
15 citations
47 days after retraction
In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds
Maral Aminpour, Marco Cannariato, Jordane Preto et al. (12 authors)
Computation Open Access
Published: Mar 2022
16 citations
46 days after retraction
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
Aleksandra Barać, Michele Bartoletti, Özlem Kurt Azap et al. (15 authors)
Clinical Microbiology and Infection Open Access
Published: Mar 2022
10 citations
44 days after retraction
Ivermectin and the Integrity of Healthcare Evidence During COVID-19
Dónal P O’Mathúna
Frontiers in Public Health Open Access
Published: Mar 2022
10 citations
22 days after retraction
Patient Betrayal: The Corruption of Healthcare, Informed Consent and the Physician-Patient Relationship
James A. Thorp, Thomas Renz, Christiane Northrup et al. (6 authors)
The Gazette of Medical Sciences Open Access
Published: Mar 2022
8 citations
22 days after retraction
Ivermectin: a mini-review
Kelly Johnson‐Arbor
Clinical Toxicology
Published: Feb 2022
37 citations
21 days after retraction
Quick Stats
Total Citations: 163
Years Since Retraction: 3.8 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Hydroxychloroquine and azithromycin as a treatment of COVID…
International Journal of Antimicrobial Agents • 4903 citations
Ivermectin role in COVID-19 treatment (IRICT): single-cente…
Expert Review of Anti-infective Therapy • 3 citations
Multifaceted role of natural sources for COVID-19 pandemic …
Environmental Science and Pollution Research • 21 citations
A novel approach to managing COVID-19 patients; results of …
European Journal of Clinical Microbiology & Infectious Diseases • 10 citations